Boston, MA, United States of America

Chase Spenser Coffman

USPTO Granted Patents = 10 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Boston, MA (US) (2021 - 2023)
  • Newton, MA (US) (2022 - 2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations by Chase Spenser Coffman: Pioneering Therapeutic Particles

Introduction

Chase Spenser Coffman, an innovative inventor based in Boston, MA, has made significant contributions to the field of pharmaceuticals with eight patents to her name. Her work focuses on the development of particles that can deliver therapeutic or diagnostic agents effectively, showcasing her commitment to advancing medical technologies.

Latest Patents

Among her latest patents, Coffman has developed technologies related to particles comprising a therapeutic or diagnostic agent and suspensions. This groundbreaking invention offers a method to create particles with high concentrations of agents while maintaining low viscosity. The electrospray method she employs not only enhances stability but also ensures that the particles can remain viable over prolonged periods without refrigeration.

Another notable patent involves methods for forming particles that include one or more agents, allowing for the preparation of various pharmaceutical and cosmetic applications. The process minimizes alterations to the structural integrity and activity of the agents, ensuring that they maintain efficacy during storage and use. This invention caters to a wide range of applications, from pharmaceutical formulations to nutraceuticals and cosmetics.

Career Highlights

Currently, Chase Coffman is associated with Elektrofi, Inc., a company that is dedicated to transforming how therapeutics are delivered. Her innovative approach and scientific rigor have earned her recognition in her field, contributing to advancements in safe and efficient drug deliveries.

Collaborations

Throughout her career, Coffman has collaborated with other notable professionals, including Paul Brown and Daniel Benjamin Dadon. These partnerships have enabled her to enhance her research capabilities and expand the scope of her inventions, leading to a stronger impact on the industry.

Conclusion

Chase Spenser Coffman represents the forefront of pharmaceutical innovation. With eight patents and a dedication to creating advanced therapeutic particles, her contributions are poised to influence the future of drug delivery systems. Through her ongoing work at Elektrofi, Inc., and collaborative efforts, she continues to push the boundaries of what is possible in the field of health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…